Coya Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €3.07M -40.8% -€12.84M +86.3% -418.7% -2.9 pp -€8.88M -8.0% -289.5% -1.0 pp
    €5.18M +∞% -€6.89M -34.8% -133.1% -1.3 pp -€9.65M +54.6% -186.4% -1.9 pp
    €0.00 +NaN% -€10.56M +150.3% N/A -€6.24M +92.2% N/A
    €0.00 +NaN% -€4.22M +567.4% N/A -€3.25M +862.6% N/A
    €0.00 -€632.28K N/A -€337.50K N/A

    Notifications